Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 1/20 | 0.65 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.65 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.65 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.65 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.65 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.44 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.42 |
| ▸ | PPARG | P37231 | 7/20 | 0.42 |
| ▸ | PPARD | Q03181 | 7/20 | 0.42 |
| ▸ | PPARA | Q07869 | 7/20 | 0.42 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.42 |
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.42 |
| ▸ | TLR2 | O60603 | 2/20 | 0.42 |
| ▸ | FABP4 | P15090 | 2/20 | 0.42 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.42 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 3-Methylbutanoic Acid SCHEMBL11446561 | 0.95 | FFAR3 (0.59) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| 3-Methylbutanoic Acid SCHEMBL5519850 | 0.95 | FFAR3 (0.59) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| 3-Methylbutanoic Acid SCHEMBL3670028 | 0.91 | FFAR3 (0.54) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| 3-Methylbutanoic Acid SCHEMBL11650777 | 0.91 | FFAR3 (0.54) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| 3-Methylbutanoic Acid SCHEMBL28746566 | 0.91 | FFAR3 (0.54) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Hexanoate SCHEMBL27645750 | 0.89 | AKR1B1 (0.64) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| 3-Methylbutanoic Acid SCHEMBL2303256 | 0.87 | TDP1 (0.48) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Succinic Acid SCHEMBL8366457 | 0.87 | LMNA (0.53) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| 3-Methylbutanoic Acid SCHEMBL18740744 | 0.86 | FFAR3 (0.48) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Hexanoate SCHEMBL27555941 | 0.86 | AKR1B1 (0.59) | FFAR3HDAC3HDAC1HDAC2HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2844691-B1 | PLASTICISER COMPOSITIONS COMPRISING GELIFICATION ACCELERATORS BASED ON ESTER(S) OF 1,4 : 3,6-DIANHYDROHEXITOL HAVING LOW MOLAR WEIGHT | ROQUETTE FRERES (FR) | 2019-08-14 | — | — | EP | claimed |
| EP-2844691-A2 | PLASTICISER COMPOSITIONS COMPRISING GELIFICATION ACCELERATORS BASED ON ESTER(S) OF 1,4 : 3,6-DIANHYDROHEXITOL HAVING LOW MOLAR WEIGHT | Roquette Frères (FR) | 2015-03-11 | — | — | EP | claimed |
| WO-2013164545-A2 | PLASTICISER COMPOSITIONS COMPRISING GELIFICATION ACCELERATORS BASED ON ESTER(S) OF 1,4 : 3,6-DIANHYDROHEXITOL HAVING LOW MOLAR WEIGHT | ROQUETTE FRERES (FR) | 2013-11-07 | — | — | WO | claimed |
| EP-2844691-B1 | PLASTICISER COMPOSITIONS COMPRISING GELIFICATION ACCELERATORS BASED ON ESTER(S) OF 1,4 : 3,6-DIANHYDROHEXITOL HAVING LOW MOLAR WEIGHT | ROQUETTE FRERES (FR) | 2019-08-14 | — | — | EP | disclosed |
| CN-101820753-B | Use of an inflammatory modulator in the manufacture of a medicament for treating a pulmonary disease state in a mammal | CELLULAR SCIENCES, INC. (US) | 2016-04-13 | — | — | CN | disclosed |
| EP-2844691-A2 | PLASTICISER COMPOSITIONS COMPRISING GELIFICATION ACCELERATORS BASED ON ESTER(S) OF 1,4 : 3,6-DIANHYDROHEXITOL HAVING LOW MOLAR WEIGHT | Roquette Frères (FR) | 2015-03-11 | — | — | EP | disclosed |
| WO-2013187891-A1 | METHOD FOR TREATING A PULMONARY DISEASE STATE IN MAMMALS BY UP REGULATING INDIGENOUS IN VIVO LEVELS OF INFLAMMATORY AGENTS IN MAMMALIAN CELLS | MARTIN ALAIN (US) | 2013-12-19 | — | — | WO | disclosed |
| WO-2013164545-A2 | PLASTICISER COMPOSITIONS COMPRISING GELIFICATION ACCELERATORS BASED ON ESTER(S) OF 1,4 : 3,6-DIANHYDROHEXITOL HAVING LOW MOLAR WEIGHT | ROQUETTE FRERES (FR) | 2013-11-07 | — | — | WO | disclosed |
| EP-2616051-A1 | PHARMACEUTICAL AND/OR DIETARY COMPOSITIONS BASED ON SHORT CHAIN FATTY ACIDS | Cosmo Technologies Ltd. (IE) | 2013-07-24 | — | — | EP | disclosed |
| US-20130115280-A1 | PHARMACEUTICAL AND/OR DIETARY COMPOSITIONS BASED ON SORT CHAIN FATTY ACIDS | COSMO TECHNOLOGIES LTD (IE) | 2013-05-09 | — | — | US | disclosed |
| WO-2012013495-A1 | PHARMACEUTICAL AND/OR DIETARY COMPOSITIONS BASED ON SHORT CHAIN FATTY ACIDS | COSMO TECHNOLOGIES LTD. (IE) | 2012-02-02 | — | — | WO | disclosed |
| CN-101820753-A | Methods of treating pulmonary disease states in mammals by up-or down-regulating indigenous in-vivo levels of inflammatory mediators in mammalian cells | CELLULAR SCIENCES INC | 2010-09-01 | — | — | CN | disclosed |
| EP-2187738-A1 | METHOD FOR TREATING A PULMONARY DISEASE STATE IN MAMMALS BY UP OR DOWN REGULATING INDIGENOUS IN VIVO LEVELS OF INFLAMMATORY AGENTS IN MAMMALIAN CELLS | Cellular Sciences, Inc. (US) | 2010-05-26 | — | — | EP | disclosed |
| WO-2009020582-A1 | METHOD FOR TREATING A PULMONARY DISEASE STATE IN MAMMALS BY UP OR DOWN REGULATING INDIGENOUS IN VIVO LEVELS OF INFLAMMATORY AGENTS IN MAMMALIAN CELLS | CELLULAR SCIENCES, INC. (US) | 2009-02-12 | — | — | WO | disclosed |
| CN-1957039-A | Amphoteric graft barrier materials | CELLRESIN TECH LLC (US) | 2007-05-02 | — | — | CN | disclosed |
| US-20070053855-A1 | Personal care products incorporating cellulosic fatty acid esters | EASTMAN CHEMICAL COMPANY | 2007-03-08 | — | — | US | disclosed |
| EP-1753817-A1 | AMPHOTERIC GRAFTED BARRIER MATERIALS | Cellresin Technologies, LLC (US) | 2007-02-21 | — | — | EP | disclosed |
| WO-2005116136-A1 | AMPHOTERIC GRAFTED BARRIER MATERIALS | CELLRESIN TECHNOLOGIES, LLC (US) | 2005-12-08 | — | — | WO | disclosed |
| US-4092473-A | MICROBIOCIDES, ANTIBIOTICS | SANRAKU OCEAN CO., LTD. (JA) | 1978-05-30 | — | — | US | disclosed |